Meta to Layoff 20%, AI Cured Dogs Cancer, Nvidia's New Chip

**Jayden Schafer** (0:00)
Welcome to the podcast. I'm your host, Jayden Schafer. Today on the podcast, we're covering the top four AI news stories happening today. There is one that I'm super excited about. I posted about this over on LinkedIn, but there is an LM engineer. He just used ChatGPT and some AI tools to design a personalized cancer vaccine for his dog and actually shrink the tumor. Nvidia is preparing to unveil its next generation of AI chips. OpenAI is reportedly working on a massive enterprise partnership with PE firms, which is kind of interesting. And then the big story I want to talk about that everyone is talking about is that Meta is preparing to lay off potentially more than 20% of its workforce while ramping up AI spending. So they're making a lot of money. They're just cutting their workforce to spend more on AI. And this is what we've already seen from a bunch of other players in the industry. So let's get into all of it and the implications in the whole industry of AI. Before we do, the biggest thing I'm super excited about today to announce is that over on my platform, AI box.ai, which gives you access to tons of different AI models for just 8.99 a month, we have just added five new audio models. So there's one that is for music, sound effects and a voice changer. All of these are over on 11 labs. And in addition, we have all of the different OpenAI voices and tons of new audio voices on 11 labs. So if you do anything with audio, music, sound effects or voice changing, go check out AI box.ai and you get access to all of these new models. I am super excited about that. And you can also build them into workflows that you can automate different things you do at work. This is something I'm doing every single day and it is saving me so much time. So go check it out. There's a link in the description to AI box.ai. It's only 8.99 a month and you get 20% off if you get an annual plan. So it's a super amazing tool that I hope it saves you a ton of time. All right, let's get into the first story today is this kind of cancer vaccine that was created for a dog. So basically this is coming out of Australia. It's pretty wild. There's a tech entrepreneur named Paul Conaham, and he decided to try something. Basically, he went to the vet and they told him that his rescue dog, Rosie, only had a few months left to live because she had a really advanced cancer. So I think instead of doing what a lot of people do, most, I mean, everyone really, and just kind of accepting the prognosis, he decided to use AI tools, including ChatGPT and then Google's Alpha Fold to analyze the tumor. So he had Rosie's healthy DNA, and then he had her DNA sequenced from the tumor, and then he converted the tumor tissue into data and used ChatGPT to identify the mutations that were driving the cancer. This is incredible.
Not because I think a lot of people will be like, oh, he's kind of in tech, so that's how he was able to do this. He has no background in biology, right? He's just literally working with ChatGPT and asking how to do this. How do I sequence DNA? How do I, like, what do I do with the tumor data that they gave me? And he was able to take all of this. And then he went and found some researchers at New South Wales and they designed a custom mRNA vaccine tailored specifically to Rosie's tumor. The thing that took the longest, because they actually got that done pretty quick, the thing that took the longest is that they had to wait three months just for the regulation to approve that it was going to be safe to vaccinate his dog, which kind of is horrible considering it only had months left to live and he's probably super stressed about it, and the regulation took longer than them cranking out this vaccine, which is with chetchi PT. And then Rosie received her first injection in December, and then by March she had about a tennis ball sized tumor, it had shrunk about 75% and continuing to shrink. So researchers believe that this might be the first kind of personalized cancer vaccine ever created for a dog, but this also will work for humans. And I think the bigger implication here is that the same approach is already being tested in humans by companies like Moderna, Merck and BioNTech. Now, of course, when we're doing humans, there's so much red tape and regulations probably won't be available for years, which is honestly a huge shame in my opinion. And don't even get me started on my thoughts on the pharmaceutical industry in this regard, and perhaps as a regulation in America, but I don't know. Not my favorite thing. It's incredible that he was able to make this for his dog really quick and get it ready in three months, a custom vaccine. So I think this obviously started out as a really desperate attempt to save his dog, but I think it's actually a preview of AI-driven personalized medicine that we're going to see more of, and hopefully we'll see this for humans in the future. Next up, Nvidia is preparing a major AI chip reveal. Nvidia's massive AI conference is called GTC. It's kicking off, and Jensen Huang is expected to unveil the company's next generation of AI chips. These chips are designed for the next wave of AI models and large-scale inference workloads. I think right now we're really entering a phase where companies aren't just training models, they're actually deploying them everywhere, and so that means that the demand for the inference compute is exploding. And Nvidia, to this point, has already become really the central infrastructure provider for the AI boom, and I think every new generation of chip basically resets the performance ceiling for the entire industry. So if Nvidia reveals another major leap, I think it's going to accelerate the entire AI ecosystem again. So that is what I would say to look out for at GTC. Another thing that's incredible right now is that OpenAI is exploring a $10 billion enterprise AI venture. They're in talks with several major private equity firms about launching a joint venture, which is focused on deploying AI across corporate America. Now why is this important? It's like, oh great, another OpenAI corporate kind of partnership. We've seen a bunch of these enterprise partnerships, yada yada. What's the big deal?